Vericel Corp
NASDAQ:VCEL

Watchlist Manager
Vericel Corp Logo
Vericel Corp
NASDAQ:VCEL
Watchlist
Price: 52.74 USD -4.92% Market Closed
Market Cap: 2.6B USD
Have any thoughts about
Vericel Corp?
Write Note

Vericel Corp
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vericel Corp
Capital Expenditures Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Vericel Corp
NASDAQ:VCEL
Capital Expenditures
-$58m
CAGR 3-Years
-94%
CAGR 5-Years
-83%
CAGR 10-Years
-93%
Abbvie Inc
NYSE:ABBV
Capital Expenditures
-$888m
CAGR 3-Years
0%
CAGR 5-Years
-12%
CAGR 10-Years
-4%
Gilead Sciences Inc
NASDAQ:GILD
Capital Expenditures
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Capital Expenditures
-$974m
CAGR 3-Years
-8%
CAGR 5-Years
-8%
CAGR 10-Years
-1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Capital Expenditures
-$481.8m
CAGR 3-Years
-30%
CAGR 5-Years
-45%
CAGR 10-Years
-25%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Capital Expenditures
-$928.1m
CAGR 3-Years
-18%
CAGR 5-Years
-20%
CAGR 10-Years
-13%

See Also

What is Vericel Corp's Capital Expenditures?
Capital Expenditures
-58m USD

Based on the financial report for Sep 30, 2024, Vericel Corp's Capital Expenditures amounts to -58m USD.

What is Vericel Corp's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-93%

Over the last year, the Capital Expenditures growth was -179%. The average annual Capital Expenditures growth rates for Vericel Corp have been -94% over the past three years , -83% over the past five years , and -93% over the past ten years .

Back to Top